Skip to content

Handheld fan for breathlessness in interstitial lung disease

Handheld fan for breathlessness in interstitial lung disease

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001949279
Enrollment
30
Registered
2018-11-30
Start date
2019-02-11
Completion date
2020-02-06
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

People with interstitial lung disease often have poor quality of life because of distressing breathlessness and reduced exercise tolerance. Their survival is often poor and there are limited medical treatments available. There is no proven treatment for relieving symptoms in patients with these conditions. Handheld fans have been shown to be a useful intervention for breathlessness in patients with other lung conditions and cancers. This study aims to explore the use of a handheld fan, a simple and easily portable device, for symptom management in people with interstitial lung disease.

Interventions

Participants randomised to use a handheld fan for symptom management. They will be provided the fan for use at home and in the community as needed for 2 weeks. There is no specific prescription for the frequency or duration of use. Participants can use the device as much or as little as they choose. Therapy usage will be monitored using a 7-day usage diary prior to each visit and the number of operated hours of portable concentrators.

Sponsors

Dr Yet Hong Khor
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Age of 18 years or older • Able to give written informed consent • Diagnosis of fibrotic interstitial lung disease of any aetiology • Modified Medical Research Council Dyspnoea Scale greater than or equal to 2

Exclusion criteria

• Significant communication or locomotor difficulties • Significant co-existing chronic obstructive pulmonary disease (defined as FEV1/FVC <60% on the most recent lung spirometry or extent of emphysema greater than extent of fibrosis on the most recent CT chest) • Unstable health condition (defined as hospitalisation for acute medical conditions) in the last 4 weeks before screening

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026